The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold

Thu, 16th Sep 2021 09:53

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

EXANE BNP RAISES STANDARD CHARTERED TO 'NEUTRAL' (UNDERPERFORM)

----------

DEUTSCHE BANK CUTS SHELL PRICE TARGET TO 1,871 (1,937) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES BP PRICE TARGET TO 320 (313) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS ANGLO AMERICAN PRICE TARGET TO 3,600 (3,700) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS ANTOFAGASTA PRICE TARGET TO 1,310 (1,320) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS RIO TINTO PRICE TARGET TO 6,000 (6,600) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS BHP GROUP PRICE TARGET TO 2,200 (2,400) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES GLENCORE PRICE TARGET TO 440 (420) PENCE - 'BUY'

----------

RBC RAISES GLENCORE PRICE TARGET TO 400 (360) PENCE - 'OUTPERFORM'

----------

GOLDMAN RAISES GLENCORE PRICE TARGET TO 430 (390) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS UNILEVER TO 'HOLD' (BUY) - PRICE TARGET 4,600 (4,800) PENCE

----------

JPMORGAN RAISES JD SPORTS FASHION TARGET TO 1,350 (1,300) PENCE - 'OVERWEIGHT'

----------

FTSE 250

----------

CREDIT SUISSE RAISES REDROW PRICE TARGET TO 745 (640) PENCE - 'OUTPERFORM'

----------

DEUTSCHE BANK RAISES REDROW PRICE TARGET TO 800 (673) PENCE - 'BUY'

----------

BARCLAYS RAISES REDROW PRICE TARGET TO 820 (810) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES REDROW PRICE TARGET TO 850 (790) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES DRAX GROUP PRICE TARGET TO 960 (550) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES VESUVIUS PRICE TARGET TO 760 (685) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS BRITVIC TO 'HOLD' ('BUY') - TARGET 950 PENCE

----------

BERENBERG RAISES TRUSTPILOT PRICE TARGET TO 440 (430) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

CITIGROUP RAISES SOUTH32 PRICE TARGET TO 200 (185) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES SOUTH32 PRICE TARGET TO 195 (165) PENCE - 'HOLD'

----------

BERENBERG CUTS PAN AFRICAN RESOURCES PRICE TARGET TO 25 (29) PENCE - 'BUY'

----------

RBC CUTS CLINIGEN PRICE TARGET TO 860 (935) PENCE - 'OUTPERFORM'

----------

BARCLAYS RAISES KEYWORDS STUDIOS TARGET TO 3,550 (3,200) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES KEYWORDS STUDIOS PRICE TARGET TO 3,700 (3,450) PENCE - 'BUY'

----------

BARCLAYS CUTS FEVERTREE DRINKS PRICE TARGET TO 2,400 (2,500) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES FEVERTREE DRINKS PRICE TARGET TO 2,200 (2,100) PENCE - 'HOLD'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
13 Feb 2019 10:43

WINNERS & LOSERS SUMMARY: Tullow Oil Up 6% After Reinstating Dividend

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------Smurfit

Read more
13 Feb 2019 10:05

Clinigen bounds upwards on purchase of Proleukin's US rights

(Sharecast News) - Clinigen Group shares jumped on Wednesday after the company signed an agreement with Novartis to acquire the US rights to its Proleukin drug for up to $210m in cash.

Read more
13 Feb 2019 08:42

Clinigen Stock Climbs As It Buys Proleukin's US Rights From Novartis

LONDON (Alliance News) - Pharmaceuticals firm Clinigen Group PLC's shares rose early Wednesday as it announced the purchase of the rights to one of Novartis International AG's were up 12%

Read more
5 Feb 2019 10:49

Clinigen Group Appoints Accountant Nick Keher Chief Financial Officer

LONDON (Alliance News) - Clinigen Group PLC on Tuesday said it appointed Nick Keher as group chief financial officer with effect from March 19.Keher replaces current CFO Martin Abell, who a

Read more
5 Feb 2019 07:56

Clinigen appoints Nick Keher as new CFO

(Sharecast News) - AIM-listed pharmaceutical and services company Clinigen Group has appointed Nick Keher as its new chief financial officer with effect from 19 March.

Read more
15 Jan 2019 09:37

Clinigen Outlook Confident As Revenue And Profit Grow In First Half

LONDON (Alliance News) - Clinigen Group PLC on Tuesday expressed confidence in delivering progress in its full financial year after it saw a strong earnings growth in the first half.The for

Read more
15 Jan 2019 09:22

Acquisitions spur Clinigen to profit and revenue growth

(Sharecast News) - Clinigen Group on Tuesday reported that, following a series of acquisitions, it expects to report a sharp rise in revenue and profit when it publishes its half-year results next month.

Read more
1 Nov 2018 16:03

UK Shareholder Meetings Calendar - Next 7 Days

Friday 2 NovemberMurgitroyd GroupMonday 5 NovemberRandgold Resources (re Barrick Gold

Read more
27 Sep 2018 17:45

UPDATE: Clinigen In Placing For Two New Purchases; Earnings Jump (ALLISS)

LONDON (Alliance News) - Clinigen Group PLC on Thursday said it placed 9.5 million shares at a price of 845 pence each, raising GBP80 million.The stock closed 11% lower on Thursday at per a

Read more
27 Sep 2018 12:14

Thursday broker round-up

(Sharecast News) - Thomas Cook Group: UBS upgrades to neutral with a target price of 60p.

Read more
27 Sep 2018 10:05

Clinigen In Share Placing For Two New Purchases; Annual Earnings Jump (ALLISS)

LONDON (Alliance News) - Clinigen Group PLC on Thursday announced a share placing to help pay for the acquisition of packaging and distribution services company CSM Parent Inc for up to USD240 in

Read more
27 Sep 2018 08:04

Clinigen announces two new acquisition targets following 'another year of good progress'

(Sharecast News) - Clinigen plans to raise £80m from investors to fund two new acquisitions following a "strong performance" from one of its previous additions in its last trading year.

Read more
20 Sep 2018 16:12

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 21 September Smiths GroupFull Year ResultsSIGHalf Year SaatchiHalf Year +

Read more
25 Jul 2018 14:40

Clinigen makes second July drug acquisition

(Sharecast News) - Pharmaceutical and services company Clinigen has acquired the global rights to severe malignant osteoperosis treatment Imukin from Horizon Pharma for an undisclosed sum.

Read more
25 Jul 2018 09:48

Clinigen Acquires Global Rights For Osteoporosis Drug Imukin

LONDON (Alliance News) - Clinigen Group PLC said Wednesday that it acquired the global rights to osteoporosis drug Imukin from Horizon Pharma PLC.The FTSE 250 pharmaceutical company said it

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.